Recent research indicates that ipafricept, a unique agent , could provide a significant development in managing fibrotic diseases . This compound functions by inhibiting activin factor- 1B-binding https://rafaelhqby025291.blognody.com/49673161/ipafricept-a-novel-therapy-for-fibrotic-conditions